benzocaine (EjectDelay)
Classes: Anesthetics, Topical; Local Anesthetics, Esters; Anesthetics, Oropharyngeal
Dosing and uses of EjectDelay (benzocaine)
Adult dosage forms and strengths
gel/topical solution
- 6.3%
- 7.5%
- 10%
- 20%
liquid
- 5%
- 6.3%
- 7.5%
- 10%
- 20%
Bee Stings, Minor Burns, Sunburn, Insect Bites
Apply 5-20% to affected area q6-8hr PRN; remove sting prior to application if a bee sting
Mouth and Gum Irritation
Apply 10-20% solution (or other topical formulation) PRn
Sore Throat/Mouth Pain
1 lozenge dissolved in mouth; repeat q2hr PRN (generally use <2 days)
Apply 1 spray to affected area; spit after 1 min; may repeat up to 4 times
Hemorrhoids
Apply 5-20% externally to affected area q4hr
Dental pain
Use 2.5-20% solution (or other topical formulation) PRn
Boils
Apply 20% to affected area; not to exceed q12hr
Premature Ejaculation
EjectDelay (7.5% gel): Apply small amount to the penis gland 15-20 min before sexual intercourse
It can be applied with or without a condom
Washed off after intercourse
Pediatric dosage forms and strengths
gel/topical solution
- 6.3%
- 7.5%
- 10%
- 20%
liquid
- 5%
- 6.3%
- 7.5%
- 10%
- 20%
Teething Pain
< 4 years
- Safety and efficacy not established
> 4 years
- Apply 7.5-10% (topical/oral) to affected gum area; not to exceed q6hr
Bee Stings, Boils, Minor Burns, Sunburn, Insect Bites
< 2 years
- Safety and efficacy not established
> 2 years
- Apply 5-20% to affected area q6-8hr PRN; remove sting prior to application if a bee sting
Mouth and Gum Irritation
<2 years: safety and efficacy not established
≥2 years: Apply 10-20% solution (or other topical formulation) PRn
Sore Throat/Mouth Pain
<5 years: Safety and efficacy not established
≥5 years
- Oral lozenge: 1 lozenge dissolved in mouth; repeat q2hr PRN (generally use <2 days)
- Oral spray: Apply 1 spray to affected area; spit after 1 min; may repeat up to 4 times
Hemorrhoids
<12 years: Safety and efficacy not established
≥12 years: Apply 5-20% externally to affected area q4hr
EjectDelay (benzocaine) adverse (side) effects
Frequency not defined
Burning
Contact dermatitis
Edema
Pruritus
Erythema
Rash
Stinging tenderness
Urticaria
Methemoglobenemia
Warnings
Contraindications
Hypersensitivity to benzocaine or other ester-type local anesthetics
Secondary bacterial infection of treated area
Cautions
Not for prolonged use
Risk of methemoglobinemia when used in mouth or throat
Pregnancy and lactation
Pregnancy category: C
Lactation: excretion in milk unknown; use with caution
Pregnancy categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA: Information not available.